Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,262
Recruiting: 2,364
Ph III recruiting: 291
Growth YoY: +11.7%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,001)

clinicaltrialsPublishedShowing 451–500 of 1,200 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07510932	Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K)(FIRST-K)	not yet recruiting	Phase 2	88	Korea University Anam HospitalOTHER	0	Apr 6, 2026	clinicaltrials
NCT07511504	Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma	not yet recruiting	Phase 2	40	OHSU Knight Cancer InstituteOTHER